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MouseMinichromosome maintenance 10 (MCM10) is a conserved, abundant nuclear protein, which plays a key role
in the initiation of eukaryotic chromosomal DNA replication and elongation. To elucidate the physiological
importance of MCM10 in vivo, we generated conventional knockout mice. No MCM10-null embryos were
recovered after E8.5, and the mutation was found to be lethal before the implantation stage. Mutant embryos
showed apparently normal growth until the morula stage, but growth defects after this stage. The dramatic
reduction of 5-bromo-2-deoxyuridine (BrdU) incorporation in the mutant embryo, followed by cell death,
suggests that defective cell proliferation may underlie this developmental failure. Taken together, these
ﬁndings provide the ﬁrst unequivocal genetic evidence for an essential and non-redundant physiological role
of MCM10 during murine peri-implantation development.nce 10; ES, embryonic stem;
o-2-deoxyuridine; DAPI, 4′-6-
leotidyl transferase-mediated
+82 31 920 2043.
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In normal healthy tissue, the cell cycle and proliferation are highly
regulated, ensuring correct duplication of the genetic contents of each
chromosome. To maintain genomic integrity, cells must ensure com-
plete and accurate DNA replication once per cell cycle [1–3]. Activation
of replication origins is a multi-step process that begins with the
ordered formation of a macromolecular protein complex, termed
the pre-replicative complex (pre-RC),which occurs during latemitosis
(M) and early G1 phases [2,4,5]. After pre-RC formation, cyclin-
dependent kinases and the DBF4-dependent CDC7 kinase promote the
transition frompre-RCs to pre-initiation complexes (pre-ICs) through-
out S phase. This step involves the recruitment of minichromosome
maintenance 10 (MCM10), CDC45, and additional initiator proteins to
the origin, which collectively promote unwinding of the origin and
recruit DNA polymerases [4,6].
MCM10 is exclusive to eukaryotes and is essential to both the
initiation and elongation phases of chromosomal DNA replication[7–10]. Yeast genetic screens identiﬁed Mcm10 as necessary for chro-
mosomal DNA replication and plasmid maintenance [11,12] and
showed MCM10 to be associated with chromatin as a component of
active replication complexes throughout S phase [8–10]. Mutations in
Mcm10 in yeast result in stalled replication, cell cycle arrest, and cell
death [11–13]. These defects can be explained by the genetic and
physical interactions between MCM10 and many essential replication
proteins, including origin recognition complex, MCM2-7, and PCNA
[11,14–23]. These genetic and physical interactions in the pre-RC and
at the replication fork indicate that MCM10 is essential for both
replisome assembly and fork progression.
While the functions of MCM10 have recently been analyzed in
Xenopus and human cancer cells [24–28], studies of the in vivo
physiological functions of MCM10 have not yet been reported. To
elucidate these physiological functions, we targeted the murine
Mcm10 gene by homologous recombination in mouse embryonic
stem cells. MCM10-null embryos showed severe growth retardation
around the morula stage and defective cell proliferation, followed by
cell death. Our analyses of MCM10-deﬁcient embryos revealed a
critical and nonredundant function of MCM10 during murine peri-
implantation development.
2. Material and methods
2.1. Murine Mcm10 gene-targeting
A 10.8-kb DNA fragment spanning the sequence from exon 2 to
exon 8 was retrieved from BAC clones (bMQ304N19, bMQ-292J10,
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procedure [29,30]. The bacterial strain SW106 was used for the BAC
recombineering. A 1.5-kb puromycin resistant cassette [31,32] was
used to replace exons 4–6 of Mcm10 (Fig. 1B). The diphtheria toxin
A chain cassette was employed as a negative selection marker. The
targeting vector was linearized and used for gene targeting in the
E14TG2a embryonic stem cell line (129OlaHsd-derived, International
Gene Trap Consortium). Electroporation of mouse ES cell culture
was performed as previously described [31]. Correctly-targeted ES
clones were injected into C57BL/6 blastocysts for chimera generation.
Chimeric males were bred with C57BL/6 females, and germ line
transmission of the Mcm10− allele was veriﬁed by PCR and Southern
blots (Fig. 1D). The DNA probe used in Southern blotting was a 968-bp
HindIII–NheI fragment containing exons 9 and 10. PCR primers and
genotyping information for the Mcm10 wild-type and mutant alleles
were described in Supplementary Table S1.
2.2. Expression of Mcm10 in embryonic cells and tissues
Reverse transcriptase PCR (RT-PCR) and quantitative real-time PCR
(Q-PCR) analyses were performed as previously described [33].D
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Total RNA from mouse ES cells, whole embryos (E7.5–E14.5), and
tissues was extracted using TRIzol reagent (Invitrogen) and 1 μg of RNA
was used for RT reactions. Total RNA from 6 to 12 embryos (E2.5, E3.5,
and E4.5) was prepared using the ArrayPure™ Nano-scale RNA
puriﬁcation kit (EPICENTRE® Biotechnologies) and used for RT
reactions.
Q-PCR reactions were performed using 5 ng of diluted cDNA,
5 pmol of each primer, 5 μl of SYBR Premix EX Taq (TaKaRa) in a ﬁnal
volume of 10 μl. cDNA was transcribed from 4 μg of total RNA by
Superscript RT III (Invitrogen). The PCR cycle conditions were as
follows: pre-incubation for 30 s at 95 °C followed by 45 cycles of 15 s
at 95 °C, 30 s at 60 °C, and 30 s at 72 °C.2.3. In vitro culture and genotyping of pre-implantation embryos
Methods of handling, culturing, and genotyping mouse embryos
were performed as previously described [31,32]. All embryos were
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Fig. 2.Mcm10 expression duringmouse embryogenesis. MouseMcm10 expression during
embryogenesis, determined by reverse transcriptase PCR (A and B) or quantitative real-
time PCR (C) analyses. RNA was prepared from mouse ES cells, whole embryos
(E2.5–E14.5), or ovaries. Gene expression was normalized against GapDH.
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2.4. BrdU incorporation assay in mouse embryonic cells
For BrdU-treated embryos, blastocysts were rinsed in phosphate-
buffered saline (PBS) and ﬁxed in fresh 4% paraformaldehyde in PBS
for 30 min at room temperature. DNA was denatured after permea-
bilization with 2N HCl-0.5% Triton X-100 for 20 min at room
temperature and washed extensively in PBS with 1.0% BSA. Blasto-
cysts were incubated with mouse anti-BrdU (Developmental Studies
Hybrydoma Bank) overnight at 4 °C. Incubation with Alex Fluor 488
secondary antibodies (Invitrogen) was performed for 1 h at 37 °C,
followed by staining with DAPI.
2.5. Statistical analysis
Student's t-test was used to compare data between two groups.
Values are expressed as the average±standard deviation and pb0.05
was considered statistically signiﬁcant.
3. Results
3.1. Disruption of the murine Mcm10 gene
To better understand the in vivo function of MCM10 in developing
and adult mice, we targeted the murine Mcm10 gene by homologous
recombination in mouse embryonic stem cells (Fig. 1B and C). The
murineMcm10 gene, located on chromosome 2A1, is composed of 20
exons with a potential translational start codon in exon 2 (NCBI
annotation of NCBI Build 37). The MCM10 protein has two conserved
domains, primase zinc ﬁnger and MCM10 superfamily (Conserved
Domain Database) (Fig. 1A). In our gene targeting strategy, exons 4, 5,
and 6 were replaced by a puromycin resistance gene cassette [31].
Consequently, only the ﬁrst 113 of the 885 amino acids of MCM10 are
correctly translated following gene disruption with the selection
cassette and the truncated MCM10 protein generated by the gene
disruption does not have both conserved domains.
The Mcm10-targeting construct was transfected by electropora-
tion into 129P2/OlaHsd-derived E14TG2a embryonic stem (ES) cells,
and puromycin-resistant clones were screened for homologous
recombination by Southern blotting with 5′ external probes and
BamHI digestion (Fig. 1B and C). Out of 196 puromycin-resistant cell
lines, 7 (3.6%) displayed the desired target. The targeted ES cell
clones were used to generate chimeric mice, which were back-
crossed with wild-type C57BL/6 mice to produce germline transmit-
ted mice (Fig. 1D).
To gain insight into the physiological functions of the MCM10
protein, Mcm10 gene expression was measured in mouse ES cells,
embryonic cells, and adult tissue by RT-PCR or Q-PCR. As shown in
Fig. 2A,Mcm10 is expressed during the pre-implantation stage and in
the ovary. Furthermore, Mcm10 is more highly expressed during
early embryogenesis (ES cell and E7.5) than during late embryo-
genesis (E12.5 and E14.5) (Fig. 2B and C). Additionally, Mcm10 has
high expression levels in several tissues, such as bone marrow,
thymus, spleen, liver, testis, and ovary, which are enriched with
proliferative and progenitor cells (Supplementary Fig. S1). The
expression pattern of the Mcm10 gene suggests that the protein is
involved in cell proliferation or has functions in undifferentiated
cells.
3.2. MCM10 is essential for peri-implantation development of mouse
embryos
Heterozygous Mcm10+/− mice were apparently normal, healthy,
and fertile with no developmental abnormalities detected during a 12-month observation period. However, after intercrossing with Mcm10-
heterozygotes and producing 128 live births, no MCM10-deﬁcient
mice were generated (Fig. 3A). These results indicate that one func-
tional Mcm10 allele is sufﬁcient to support full embryonic and tissue
development, whereas inactivation of both alleles leads to embryonic
lethality.
To assess the speciﬁc period of developmental failure, mutant
embryos or fetuses were collected at different times of gestation and
genotyped by PCR (Fig. 1E). No homozygous mutant embryos/fetuses
were recovered at E8.5 or beyond, and embryos tended to be completely
resorbed by E7.5 (Figs. 3A and 4B). To further deﬁne the defects in peri-
implantation development of MCM10-null embryos, embryos at E3.5
were recovered and genotyped from heterozygous intercrosses
(Fig. 3A). All embryos were divided into four categories according to
appearance: morula, normal blastocyst, abnormal (small) blastocyst, or
dead embryo (Fig. 3B). Whereas most normal morulas and blastocysts
were wild-type or heterozygote, all abnormal (small) blastocysts and
dead embryos were Mcm10−/−. Of the embryos, 21.3% (38/178) were
homozogous Mcm10−/−, which is slightly lower than predicted by
Mendel's law. Abnormal (small) blastocysts had a small blastocoel
cavity and inner cell mass. Accordingly, we concluded that MCM10-
deﬁcient embryos were defective in peri-implantation development.
To characterize the growth defects ofMCM10-null embryos in peri-
implantation development, 2-cell embryos recovered at E1.5 were
cultured in vitro for several days (Fig. 3C).Wild-type and heterozygote
2-cell embryos underwent continual cell division and developed
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Abnormal (small)
blastocyst 0 0 12
Dead embryo 0 0 20
44 (25%) 96 (54%) 38 (21%)
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Fig. 3.MCM10 deﬁciency causes early embryonic lethality. (A) Genotypes of progeny fromMcm10-heterozygous intercrosses. After heterozygous intercrosses, neonates or embryos
were recovered at the indicated embryonic days. Genotypes were determined by PCR with genomic DNA prepared from tails or whole embryos. (B) Embryos from Mcm10-
heterozygous intercrosses recovered at E3.5. Embryos were divided into four categories according to their appearance: morula, normal blastocyst, abnormal (small) blastocyst, or
dead embryo. (C) Pre-implantation development of MCM10-deﬁcient embryos from the 2-cell to the blastocyst stage. The 2-cell embryos were recovered at E1.5 from heterozygous
intercrosses. The numbers specify the amount of time in culture.
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by the formation of a blastocoel cavity, inner cell mass (ICM), and a
trophoblast. Conversely, MCM10-deﬁcient 2-cell embryos displayed
normal development until 48 h, around the morula stage, then ceased
growing and showed an abnormal, dead appearance with most
displaying gross cellular degeneration and absence of distinct inner
cell mass or blastocoels.
Of mutant embryos collected at E3.5 from heterozygous inter-
crosses, some embryos were blastocyst-like, meaning that they were
smaller than wild-type and had small blastocoels (Fig. 3B). Therefore,
we ascertained whether these small blastocysts showed outgrowth.
After culturing for 3 days, spherical blastocysts ﬂattened out on the
culture dish and formed a multicomponent structure in which ICM
grew as a round shape on top of the extraembryonic trophoblast giant
(TG) cells (Fig. 4A) [35]. In these cultures, wild-type and heterozygote
embryonic cells normally develop into ICM and TG cells. However,
homozygoteMcm10−/− embryos did not continue to grow, andmost of
the cells were dead. Hematoxylin and eosin staining of histological
sections of E7.5 embryo frequently revealed complete resorption of the
embryos (Fig. 4B). Taken together, these data indicate that MCM10-deﬁcient embryos are defective in peri-implantation development and
show a growth defect after the morula stage.
3.3. Defective cell proliferation and cell death in MCM10-null embryos
Based on our observation of peri-implantation developmental
failure, we hypothesized that MCM10-deﬁcient embryos were
defective in proliferation and DNA replication. A number of reports
suggest that MCM10 protein is essential for initiation of DNA
replication and elongation [10,13,18,22]. We initially used in vitro
cultures of embryos to determine whether the developmental
failure of MCM10-deﬁcient embryos resulted from defective cell
proliferation, which was indirectly measured using BrdU incorpo-
ration. Speciﬁcally, embryos recovered at E2.5 were cultured in vitro
for 12 h, then pulse-labeled for 15 min with BrdU, and BrdU-
positive cells were quantiﬁed by indirect immunoﬂuorescence
(Fig. 5A). As shown in Fig. 5B, we detected about 79% BrdU-positive
cells in wild-type embryos after 12 h in culture. However, fewer
than 10% BrdU-positive cells were detected in mutant embryos, and
around 50% of mutant embryos had no BrdU-positive cells,
E 7.5
WT mut
B
A E3.5 48 hr24 hr 72 hr
X40 X40 X20X40
WT
+/-
-/-
-/-
-/-
ICM
TG
Fig. 4. Defective outgrowth of MCM10-deﬁcient blastocysts. (A) Blastocysts were
recovered from heterozygous intercrosses at E3.5, then cultured in vitro as described in
the Material and methods. The numbers specify the amount of time in culture.
(B) Hematoxylin and eosin staining of histological sections was used to analyze the
appearance of E7.5 embryos developing in the uterus. Typical pictures of wild-type and
fully resorbed mutant embryos are displayed in the left and right panels, respectively.
Scale bar=100 μm.
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suggest that defective proliferation in MCM10-null cells could, at
least in part, induce the developmental failure observed in MCM10-
null embryos.
Most MCM10-deﬁcient embryos did not grow after E3.5, andmany
of the cells were replicatively-inactive. In view of these ﬁndings, we
hypothesized that the defects in DNA replication in MCM10-deﬁcient
cells result in increased cell death in mutant conceptuses and,
eventually, destruction of the entire embryo. Consistent with this
theory, 4′,6-diamidino-2-phenylindole (DAPI) staining revealed the
presence of numerous fragmented nuclei, a hallmark of apoptotic
cells, in MCM10-null embryos at E3.5 (Fig. 5C). This was further
conﬁrmed using the cell death detection assay. Following in vitro
culture and terminal deoxynucleotidyltransferase-mediated dUTP-
biotin nick end labeling (TUNEL) staining, TUNEL-positive cells were
readily detected in homozygous Mcm10−/− embryos, but rarely inwild-type littermates (Fig. 5C and D). Collectively, our data suggest
that growth ceases in homozogous Mcm10−/− embryos due to
extensive cell death and that embryos subsequently die around the
implantation stage.4. Discussion
Our analysis of MCM10-deﬁcient embryos disclosed a critical and
nonredundant function of MCM10 during murine peri-implantation
development, which was supported by several observations. First,
Mcm10 is highly expressed during pre-implantation stage and early
embryogenesis (Fig. 2). Second, noMcm10−/− embryos or mice were
recovered after E8.5, and about 15% of embryos at E7.5 were fully
resorbed. Of embryos recovered at E3.5, all abnormal blastocysts and
dead embryos wereMcm10−/−. Third, the dramatic reduction of BrdU
incorporation in mutant embryos, followed by cell death, suggests
that defective cell proliferation underlies the developmental failure
and is the predominant phenotype of MCM10 deﬁciency in vivo, at
least in the early embryo.
In in vitro cultures of 2-cell embryos, mutant embryos
appeared to grow normally until 48 h, corresponding to the
morula stage, at which time growth ceased and the embryos
appeared to be dead (Fig. 3C). The survival of the MCM10-
deﬁcient cells until the morula stage suggests that maternal
Mcm10 mRNA and/or protein is sufﬁcient to sustain MCM10
levels through several cell divisions during early embryogenesis.
This is supported by the detection of Mcm10 mRNA in the ovary
and during E2.5 to E4.5 (Fig. 2A). It has been reported that
maternal mRNA and/or proteins are accumulated in the oocyte
cytoplasm during its growth phase and are used to sustain the
early phases of embryonic development in the absence of zygotic
expression [36]. However, insufﬁcient MCM10 remains at the
morula stage, leading to embryonic cell death.
Mice from several strains engineered to lack proteins involved in
replication initiation, elongation, and checkpoint die at the peri-
implantation stage, including Psf1 [37], Cdc45 [38], and Cdc7 [39]
mutants. Thesemice die due to defects in cell proliferation resembling
those identiﬁed in the MCM10-deﬁcient embryos, suggesting that
these factors are essential for DNA replication, cell proliferation, and
early embryogenesis.
This report is the ﬁrst attempt to access the physiological function
of MCM10 protein using Mcm10 knockout mouse and clearly implies
that MCM10 is required for early embryogenesis. However, as the
Mcm10 mutation in mice was difﬁcult to study due to the severity of
the phenotype, tissue-speciﬁc experiments in mice are required for
further clariﬁcation of MCM10 function. As Mcm10 is expressed in
many tissues, including lymphoid organs, liver, testis, and ovary
(Supplementary Fig. 1), tissue-speciﬁc experiments in mice should
reveal the physiological functions of this protein.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.05.012.Conﬂicts of interest
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Fig. 5. Defect in cell proliferation and cell death of Mcm10−/− embryos. (A) Cell proliferation was assessed by BrdU incorporation in in vitro-cultured embryos from heterozygous
intercrosses recovered at E2.5. Embryos were cultured in vitro for 12 h, pulsed for 15 min with BrdU, and processed for BrdU immunostaining and DAPI counterstaining. The
magniﬁcation is 40×. (B) A series of z-plan images was stacked and analyzed by confocal microscopy (Zeiss) to precisely quantify the percentage of BrdU-positive cells in wild-type
and mutant embryos. Values are expressed as the average±standard deviation and p-value was determined by a t-test. (C) Increased apoptosis in mutant embryos. DNA
fragmentation associated with apoptosis was determined using an in situ cell death detection kit (Chemicon), according to manufacturer's instructions. Merged images were
obtained from representative wild-type and mutant embryos recovered from heterozygous intercrosses at E2.5, cultured for 24 h, and processed for DAPI and TUNEL staining. The
magniﬁcation is 40×. (D) Quantiﬁcation of TUNEL-positive cells in wild-type and mutant embryos. Values are expressed as the average±standard deviation and p-value was
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